Search Tag: Women's Health

Women's Health

Hologic Opens New Innovation Center in France

2022 24 Mar

Innovation Center in Aix-en-Provence, France (Photo: Business Wire) --The state-of-the-art facility in Aix-en-Provence also serves as the new headquarters of Hologic France-- Hologic, Inc, an innovative medical technology company primarily focused on improving women’s health, opened its new Innovation Center in Aix-en-Provence,... Read more

Women's Health

Breast Imaging: Predictive and Prognostic Models [ECR 2022]

2022 14 Mar

Dr Michael Fuchsjäger, Chairman of the ESR Board of Directors (Graz, Austria) and Iva Biondić Špoljar of University Hospital Dubrava (Zagreb, Croatia) co-moderated a session on predictive and prognostic models in breast imaging. In this session, three experts presented on the use of Magnetic Resonance Imaging (MRI) markers in neoadjuvant chemotherapy for... Read more

Women's Health

Cervical Smear Tests Could Be Used One Day to Detect Early Breast Cancer

2022 14 Feb

Cervical smear tests one day could be used to detect early breast and ovarian cancer. A European research team recently published in Nature Communications an epigenetic signature for breast and ovarian cancer that can be easily assayed in cervical smear samples.   DNA methylation is an epigenetic mechanism to control gene expression. Greater methylation... Read more

Women's Health

Low Breast Cancer Risk Does Not Justify Infrequent Screening

2022 08 Feb

A new study from Australia found that 41% of screen-detected breast cancers occurred in women with no recorded risk factors.   Globally and in Australia, there’s been interest in risk-stratified breast screening to improve benefits while reducing screening-associated harms.Increasing screening frequency or more sensitive imaging would be used for... Read more

Women's Health

NGS Fails to Improve Triple-Negative Breast Cancer Outcomes

2022 13 Jan

Triple-Negative Breast Cancers (TNBCs) are more challenging to treat because they are not driven by estrogen receptors, progesterone receptors, or excess HER2 protein, typical targets for breast cancer therapeutics. Thus no standard therapy has shown proven efficacy for treating this patient population. Furthermore, this group of patients, which account... Read more